Edwards Lifesciences (EW) Assets Average (2010 - 2026)

Edwards Lifesciences' Assets Average history runs 17 years deep, the most recent figure standing at $13.5 billion for Q1 2026.

• On a quarterly basis, Assets Average rose 3.61% year-over-year to $13.5 billion in Q1 2026; TTM through Mar 2026 was $13.5 billion, a 3.61% increase from a year earlier, with the FY2025 full-year figure at $13.4 billion, up 19.33% from the prior year.
• Assets Average was little changed at $13.5 billion in Q1 2026 per EW's latest filing, from $13.5 billion in the prior quarter.
• Across five years, Assets Average topped out at $13.5 billion in Q1 2026 and bottomed at $8.4 billion in Q2 2022.
• The 5-year median for Assets Average is $9.5 billion (2024), against an average of $10.6 billion.
• Across the five-year window, Assets Average rose 0.13% in 2023 and surged 38.93% in 2024, its largest moves.
• Year by year, Assets Average stood at $8.5 billion in 2022, then advanced by 10.65% to $9.4 billion in 2023, then jumped by 38.93% to $13.0 billion in 2024, then advanced by 3.62% to $13.5 billion in 2025, then advanced by 0.18% to $13.5 billion in 2026.
• Per Business Quant, the three latest EW Assets Average figures stand at $13.5 billion (Q1 2026), $13.5 billion (Q4 2025), and $13.4 billion (Q3 2025).